Literature DB >> 1130028

Isoniazid-associated hepatitis--serum enzyme determinations and histologic features.

J E Lewis, P Mello, C M Knauer.   

Abstract

A prospective study of 208 patients treated for up to 12 months with isoniazid (INH((R))) for tuberculosis prophylaxis was made. Levels of serum glutamic oxaloacetic acid transaminase (SGOT) became elevated in 20 percent of the adults followed and in 30 percent predominantly nonspecific symptoms developed, in 11 percent simultaneously with SGOT elevation; SGOT levels became elevated in two of 33 children and 1 was symptomatic. Mild SGOT elevations in asymptomatic adults were self-limited; however, a small percentage of symptomatic adults showed prolonged SGOT elevation for months after INH was completed. Results of liver biopsy studies in the early stages of SGOT elevation generally showed portal and periportal lymphocytic infiltrations with lesser numbers of plasma cells, neutrophils and eosinophils.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1130028      PMCID: PMC1129751     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  14 in total

1.  ISONIAZID, PARA-AMINOSALICYLIC ACID, AND STREPTOMYCIN INTOLERANCE IN 1,744 PATIENTS. AN ANALYSIS OF REACTIONS TO SINGLE DRUGS AND DRUG GROUPS PLUS DATA ON MULTIPLE REACTIONS, TYPE AND TIME OF REACTIONS, AND DESENSITIZATION.

Authors:  S J BERTE; J D DIMASE; C S CHRISTIANSON
Journal:  Am Rev Respir Dis       Date:  1964-10

2.  Fatal hepatic necrosis secondary to isoniazid therapy.

Authors:  R COHEN; M H KALSER; R V THOMSON
Journal:  JAMA       Date:  1961-06-10       Impact factor: 56.272

3.  Drug-induced hepatic injury.

Authors:  H POPPER; F SCHAFFNER
Journal:  Ann Intern Med       Date:  1959-12       Impact factor: 25.391

4.  A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.

Authors:  S REITMAN; S FRANKEL
Journal:  Am J Clin Pathol       Date:  1957-07       Impact factor: 2.493

5.  Isoniazid: a review with emphasis on adverse effects.

Authors:  A L Goldman; S S Braman
Journal:  Chest       Date:  1972-07       Impact factor: 9.410

6.  Isoniazid hepatitis.

Authors:  W C Maddrey; J K Boitnott
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

7.  Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.

Authors:  W C Bailey; S L Taylor; H E Dascomb; H B Greenberg; M M Ziskind
Journal:  Am Rev Respir Dis       Date:  1973-04

8.  Isoniazid toxicity. A prospective study in secondary chemoprophylaxis.

Authors:  C B Byrd; R Nelson; R C Elliott
Journal:  JAMA       Date:  1972-06-12       Impact factor: 56.272

9.  Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.

Authors:  L Scharer; J P Smith
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

10.  Pharmacology of isonicotinic acid hydrazide (nydrazid).

Authors:  B RUBIN; G L HASSERT; B G H THOMAS; J C BURKE
Journal:  Am Rev Tuberc       Date:  1952-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.